Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Smruthi OrganicsBOM:540686 -2.31%66 Days Inventory is 179.49 as of Mar. 2026, which is 68% above its 10-year median of 106.78. GuruFocus rates BOM:540686 with a GF Score™ of 66/100 and a GF Value™ of ₹107.43 (Fairly Valued). The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, Smruthi Organics ranks worse than 68.69% on this metric.
The historical rank and industry rank for Smruthi Organics's Days Inventory or its related term are showing as below:
BOM:540686'
s Days Inventory Range Over the Past 10 Years
Min: 84.55 Med: 106.78 Max: 227.98
Current: 218.88
During the past 13 years, Smruthi Organics's highest Days Inventory was 227.98. The lowest was 84.55. And the median was 106.78.
BOM:540686's Days Inventory is ranked worse than 68.69% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs BOM:540686: 218.88
Smruthi Organics's Days Inventory
increased
from Mar. 2025 (115.80) to Mar. 2026 (179.49).
It might indicate that Smruthi Organics's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Smruthi Organics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.51.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Smruthi Organics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.97.
Smruthi Organics (BOM:540686) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Smruthi Organics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Smruthi Organics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Smruthi Organics Days Inventory Related Terms
Smruthi Organics Days Inventory Historical Data
* Premium members only.
The historical data trend for Smruthi Organics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540686 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Smruthi Organics Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Smruthi Organics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Smruthi Organics (BOM:540686) has a Days Inventory of 179.49 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Smruthi Organics and its competitors. This is 68% above median its historical median of 106.78. Over the past decade, Smruthi Organics' Days Inventory has ranged from 84.55 to 227.98. According to the industry distribution chart, Smruthi Organics ranks #634 out of 923 companies in the Drug Manufacturers industry, placing it in the top 68.7%.
Is Smruthi Organics' Days Inventory too high?
Smruthi Organics' current Days Inventory of 179.49 is 68% above median its 10-year median of 106.78. Over the past 10 years, this metric has ranged from a low of 84.55 to a high of 227.98. The Drug Manufacturers industry median Days Inventory is 164.38. Smruthi Organics' value of 179.49 is 9.2% above this industry median. Based on the distribution chart, Smruthi Organics ranks #634 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Smruthi Organics has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Smruthi Organics' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Smruthi Organics ranks #634 out of 923 companies for Days Inventory. This places Smruthi Organics in the lower half of its industry. The industry median Days Inventory is 164.38. Smruthi Organics' value of 179.49 is 9.2% above this benchmark. Historically, Smruthi Organics' own Days Inventory has ranged from 84.55 to 227.98 over the past decade. While the company's 10-year median is 106.78 vs. the industry median of 164.38, Smruthi Organics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Smruthi Organics's current Days Inventory of 179.49 is 9.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Smruthi Organics and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Smruthi Organics's current Days Inventory is 179.49, which is 68% above median its own 10-year median of 106.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smruthi Organics stock overvalued right now?
Based on GuruFocus' analysis, Smruthi Organics (BOM:540686) is currently considered Fairly Valued. The stock's GF Value™ is ₹107.43, compared to a current price of ₹116.05 — trading 8% above its estimated fair value. The current Days Inventory is 179.49, which is 68% above median its 10-year median of 106.78 and 9.2% above the Drug Manufacturers industry median of 164.38. Smruthi Organics' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Smruthi Organics (BOM:540686), the current Days Inventory is 179.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Smruthi Organics (BOM:540686) Overvalued in 2026?
Based on GuruFocus' analysis, Smruthi Organics stock appears to be overvalued.
The current stock price of ₹116.05 is trading 8% above its estimated GF Value™ of ₹107.43.
GuruFocus considers Smruthi Organics to be Fairly Valued.
Key valuation signals for BOM:540686:
Days Inventory: 179.49 (68% above median its 10-year median of 106.78)
GF Value™: ₹107.43 vs. price of ₹116.05 (8% above fair value)
Industry Position: 9.2% above the Drug Manufacturers median (#634 of 923)
No single metric tells the full story. See the BOM:540686 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium, and many more. It has two reportable business segments: Bulk Drugs and Drugs Intermediates (API), and Formulation. It generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment. Geographically, the company generates maximum revenue from outside India through exports, and the rest from its business within India.
66GF Score
Get the complete analysis for BOM:540686
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540686 has been successfully added to your 
